H. A. Dieterich

Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren in Combination With Digoxin, Atorvastatin, and Ketoconazole in Healthy Subjects: The Role of P‐Glycoprotein in the Disposition of Aliskiren

Sujata Vaidyanathan, Gian Camenisch, Helmut Schuetz et al. · The Journal of Clinical Pharmacology · 2008 · 103 citations

Medicine, Pharmacokinetics, Pharmacology +13

Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers

Sujata Vaidyanathan, Jessica Valencia, Charisse Kemp et al. · International Journal of Clinical Practice · 2006 · 87 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetics of the Oral Direct??Renin Inhibitor Aliskiren Alone and??in Combination with Irbesartan in??Renal Impairment

Sujata Vaidyanathan, Hilde Bigler, C M Yeh et al. · Clinical Pharmacokinetics · 2007 · 67 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Aliskiren Exhibits Similar Pharmacokinetics in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus

Charlie W. Zhao, Sujata Vaidyanathan, Ching‐Ming Yeh et al. · Clinical Pharmacokinetics · 2006 · 66 citations

Medicine, Pharmacokinetics, Pharmacology +10

Pharmacokinetics, Safety, and Tolerability of the Oral Renin Inhibitor Aliskiren in Patients With Hepatic Impairment

Sujata Vaidyanathan, Vance Warren, Ching‐Ming Yeh et al. · The Journal of Clinical Pharmacology · 2007 · 61 citations

Pharmacy, Pharmacokinetics, Pharmacology +16